Abu Dhabi Stem Cell Centre announces success in advanced trial for autoimmune diseases
Advanced-stage trial data showed more than 85% improvement in biomarkers and a reduction in inflammatory symptoms, the centre says
The Abu Dhabi Stem Cell Centre (ADSCC) on Thursday, November 12, 2026, announced a major scientific and medical achievement in an advanced-stage clinical trial to develop an innovative cell therapy for chronic autoimmune diseases. The treatment uses immune-modulation techniques involving stem cells extracted from the patients themselves.
Promising therapeutic results and reduced reliance on conventional medicines
Clinical data released by the centre showed a marked improvement of more than 85% in biomarkers among participating patients, along with a sharp reduction in inflammatory symptoms and a lower need for immunosuppressive medicines associated with side effects. The findings offer fresh hope to millions of patients worldwide.
World-class research laboratories and Emirati expertise
The centre’s research team said the work was conducted entirely at its advanced laboratories in Abu Dhabi, in line with the highest international medical protocols and with the participation of leading Emirati and international doctors and scientists. International patents have also been registered to protect the therapeutic innovation.
Strengthening Abu Dhabi’s leadership in life sciences and medical research
The scientific achievement reinforces Abu Dhabi’s standing as a leading regional and global hub for advanced medical research and regenerative medicine. The UAE continues to support scientific innovation and provide the technological capabilities needed to improve the quality of healthcare.